Cover Image

Orphan drug reauthorization : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Third Congress, second session on H.R. 4160, a bill to amend the Federal Food, Drug, and Cosmetic Act, the Public Health Service Act, and the Orphan Drug Act to revise the provisions of such acts relating to orphan drugs, June 16, 1994.

Bibliographic Details
Corporate Authors:	United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment, ProQuest (Firm)
Format:	Government Document eBook
Language:	English
Published:	Washington : U.S. G.P.O. : 1994.
Series:	U.S. Congressional Hearings.
Subjects:	Drugs > Law and legislation > United States. Orphan drugs > United States. Pharmaceutical industry > Research > United States. Electronic books.
Online Access:	Connect to the full text of this electronic book

Similar Items

The Orphan Drug Act : implementation and impact /
Published: (2001)

The Orphan Drug Act and Catalyst Pharmaceuticals, Inc., v. Becerra /
by: Rogers, Hannah-Alise
Published: (2023)

The Orphan Drug Act : legal overview and policy considerations /
by: Rogers, Hannah-Alise, et al.
Published: (2024)

Orphan Drugs : understanding the rare disease market and its dynamics /
Published: (2012)

Anticompetitive Abuse of the Orphan Drug Act : invitation to high prices : hearing before the Subcommittee on Antitrust, Monopolies, and Business Rights of the Committee on the Judiciary, United States Senate, One Hundred Second Congress, second session, on S. 2060, a bill to revise the orphan drug provisions of the Federal Food, Drug, and Cosmetic Act, the Public Health Service Act, and the Orphan Drug Act, and for other purposes, January 21, 1992.
Published: (1992)

Orphan drugs : medical versus market value /
by: Asbury, Carolyn H.
Published: (1985)

Fairness in Orphan Drug Exclusivity Act : report (to accompany H.R. 4712).
Published: (2020)

Orphan Drug Amendments of 1991 : hearing before the Committee on Labor and Human Resources, United States Senate, One Hundred Second Congress, second session, on S. 2060 ... Tuesday, March 3, 1992.
Published: (1992)

Food and Drug Amendments of 2022 : report of the Committee on Energy and Commerce (to accompany H.R. 7667).
Published: (2022)

Orphan Drug Act : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, second session, February 7, 1990.
Published: (1990)

Orphan Drug Act : Background and Proposed Legislation in the 107th Congress.
Published: (2001)

Orphan drugs : your complete guide to effective, tested medications outside the U.S. and their availability /
by: Anderson, Kenneth N.
Published: (1983)

Orphan Drug Amendments of 1994.
Published: (1994)

Orphan Drug Act.
Published: (1982)

Orphan Drug Act Amendments of 1994.
Published: (1994)

Rare diseases and orphan drugs : keys to understanding and treating the common diseases /
by: Berman, Jules J.
Published: (2014)

Report of the National Commission on Orphan Diseases.
Published: (1989)

Expert opinion on orphan drugs.
Published: (2013)

Drug issues : hearings before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundredth Congress, October 1, 1987--Orphan Drug Amendments of 1987 (H.R. 3349), October 5, 1987--Generic Animal Drug and Patent Term Restoration Act (H.R. 3120), May 16, 1988--Consumer Product Safe Testing Act (H.R. 1635).
Published: (1988)

Orphan Drug Amendments of 1990.
Published: (1990)

The applicability of the export proviso of the Federal Food, Drug, and Cosmetic Act to "new drugs" /
by: Gilmore, Cathy
Published: (1985)

Pricing of drugs codeveloped by federal laboratories and private companies : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, first session, Washington, DC, January 25, 1993.
Published: (1993)

Drug Listing Act of 1972.
Published: (1972)

The Food and Drug Administration's process for approving new drugs : report /
Published: (1980)

Reauthorization of the Drug Enforcement Administration : hearing before the Subcommittee on Crime of the Committee on the Judiciary, House of Representatives, Ninety-seventh Congress, first session, on reauthorization of the Drug Enforcement Administration, March 12, 1981.
Published: (1983)

Guidance for industry : interpreting sameness of monoclonal antibody products under the orphan drug regulations.
Published: (1999)

Orphan Drug Amendments of 1992.
Published: (1992)

Optimizing the "drug-like" properties of leads in drug discovery /
Published: (2006)

FDA and the drug development process : how the agency ensures that drugs are safe and effective.
Published: (2002)

Drug topics red book.
Published: (1995)

Orphan drugs and rare diseases /
Published: (2014)

Drug safety : an update from the Food and Drug Administration : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, second session, March 10, 2010.
Published: (2012)

FDA drug bulletin.
Published: (1971)

Drug export reform : hearing before the Committee on Labor and Human Resources, United States Senate, Ninety-ninth Congress, first session, on proposed legislation to amend the Federal Food, Drug, and Cosmetic Act ... June 5, 1985.
Published: (1986)

Competitive problems in the drug industry : drug testing : summary and analysis /
Published: (1979)

Marketing prescription drugs /
by: King, Donald C., 1930-
Published: (1968)

Drug-drug interactions in pharmaceutical development /
Published: (2008)

Regulating new drugs /
Published: (1973)

Drug regulation reform--oversight : hearing before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, second session ...
Published: (1980)